Blue Crest Capital Management LTD United Therapeutics Corp Transaction History

Blue Crest Capital Management LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$205.95 - $280.43 $4.8 Million - $6.53 Million	23,290 New	23,290 $6.48 Million
Q1 2018 May 15, 2018	SELL	$107.21 - $151.94 $330,635 - $468,582	-3,084 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$118.58 - $151.28 $1.09 Million - $1.39 Million	-9,183 Reduced 74.86%	3,084 $456,000
Q3 2017 Nov 14, 2017	BUY	$114.6 - $136.81 $1.41 Million - $1.68 Million	12,267	12,267 $1.44 Million

669

42.8M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $17B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Blue Crest Capital Management LTD with notifications on news.